Advertisement

Topics

Infinity To Present At The 2017 BIO Investor Forum

04:41 EDT 10 Oct 2017 | PR Newswire

CAMBRIDGE, Mass., Oct. 10, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 2017 BIO Investor Forum on Tuesday, October 17, 2017, at 10:45 a.m. PT (1:45 p.m. ET) in San Francisco, CA. A live webcast of Infinity's presentation will be accessible on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.

About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1 study in patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:Jaren Irene Madden, Senior Director,
Investor Relations and Corporate Communications
617-453-1336 or Jaren.Madden@infi.com

View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-the-2017-bio-investor-forum-300532737.html

SOURCE Infinity Pharmaceuticals, Inc.

NEXT ARTICLE

More From BioPortfolio on "Infinity To Present At The 2017 BIO Investor Forum"

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...